Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00378638
Title Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Chap, Linnea I., M.D.
Indications

breast cancer

Therapies

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.